What is the global market size of Needles Market?

Needles Market size was valued at USD 6.51 billion in 2021 and is poised to grow from USD 7.06 billion in 2022 to USD 12.6 billion by 2030, growing at a CAGR of 8.6% in the forecast period (2023-2030).

Needles Market Size, Share, Growth Analysis, By Type(Conventional Needles, Safety Needles), By Product(Suture Needles, Blood Collection Needles, Ophthalmic Needles, Dental Needles), By Delivery Mode(Hypodermic Needles, Intravenous Needles, Intramuscular Needles, Intraperitoneal Needles), By Region - Industry Forecast 2024-2031

Q: Who are the key vendors in the Global Needles Market?

The global needles market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. 'Becton, Dickinson and Company', 'Terumo Medical Corporation', 'B. Braun Melsungen AG', 'Smiths Medical', 'Nipro Corporation', 'Medtronic ', 'Novo Nordisk A/S', 'Ypsomed Holding AG', 'Owen Mumford Ltd.', 'Gerresheimer AG', 'HTL-STREFA S.A.', 'Retractable Technologies, Inc.', 'Vygon S.A.', 'Codan Medizinische Geräte GmbH & Co. KG', 'Exelint International Co.', 'MHC Medical Products', 'Catalent, Inc.', 'Mylan N.V.', 'Vita Needle Company', 'TSK Laboratory Europe B.V'

Report ID: SQSG35A2036 | Region: Global | Published Date: February, 2024
Pages: 225 | Tables: 94 | Figures: 76

Needles Market News

In July 2022, Thermo Fisher Scientific and Hologic both presented updates to their current lineups of respiratory virus tests. The new test panels are originally available in the European Union with CE mark clearance and screen for several prevalent viruses at once, including COVID-19, the flu, the common cold, respiratory syncytial virus, pneumonia, and more.
In April 2022, together with a new decentralized clinical trial (DCT) solution, Thermo Fisher Scientific Inc.'s PPD clinical research division and Matrix Clinical Trials, a Matrix Medical Network service, are bringing clinical trials to patients. To assist find, attracting, and retaining trial participants while guaranteeing a favorable patient experience, the company is deploying cutting-edge Matrix mobile research sites and knowledgeable clinical personnel across the U.S. The two businesses are simultaneously looking for ways to extend their partnership to new regions.

Needles Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Needles Market size was valued at USD 6.51 billion in 2019 and is poised to grow from USD 7.06 billion in 2023 to USD 12.6 billion by 2031, growing at a CAGR of 8.6% in the forecast period (2024-2031).

The needles market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. 'Becton, Dickinson and Company', 'Terumo Medical Corporation', 'B. Braun Melsungen AG', 'Smiths Medical', 'Nipro Corporation', 'Medtronic ', 'Novo Nordisk A/S', 'Ypsomed Holding AG', 'Owen Mumford Ltd.', 'Gerresheimer AG', 'HTL-STREFA S.A.', 'Retractable Technologies, Inc.', 'Vygon S.A.', 'Codan Medizinische Geräte GmbH & Co. KG', 'Exelint International Co.', 'MHC Medical Products', 'Catalent, Inc.', 'Mylan N.V.', 'Vita Needle Company', 'TSK Laboratory Europe B.V'

During the projected period, the market for needles is anticipated to rise more quickly due to the rising incidence of different chronic diseases and the rising number of hospitals and clinics in developing nations. It is anticipated that major businesses will continue to invest heavily in research and development to bring the most safe and precise needle technology to market. In order to allow surgeons to examine specific blood arteries at danger when placing the needle and prevent deadly bleeding, a research team from the University of Adelaide created a biopsy needle coupled to a tiny imaging probe in January 2018.

In the projection period of 2022 to 2028, an increase in public-private financing for targeted research activities, an increase in the elderly population, and favorable regulatory policies for the approval of novel injectables will expand the market's lucrative potential. In the future, the market's growth rate will be further accelerated by factors such as the rising number of strategic alliances, the internet penetration rate, the expansion of hospitals and laboratories, the rise in drug self-administration, the use of safety needles, and the per capita spending on health care.

The needles market is dominated by North America due to the region's strong base of healthcare facilities, growing investment from major players in the development of cutting-edge devices, well-established distribution networks for needle product manufacturers, and an increase in research activities. For example, in 2021, investors closed 96 Medtech investments, a substantial increase from 55 in 2020 and a record-breaking 60 in 2018. Deal value increased to $40.8 billion from $3 billion in 2020, mostly because of the $34 billion Medline deal. Such fluctuations are typical in the industry, where substantial assets are not as common. Supply chain resilience and cost control, technology for alternative treatment, specialist contract manufacturing, and regulatory assistance are important issues for investors in North America and Europe.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Needles Market News

Needles Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Needles Market?

Who are the key vendors in the Needles Market?

What is the key driver of Needles Market?

What is the key market trend for Needles Market?

Which region accounted for the largest share in Needles Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300